SimvAstatin in Neurofibromatosis Type 1-Autism (SANTA)

• Research type

  Research Study

• Full title

  Early phase triple blind placebo controlled RCT of simvastatin treatment for autism in young children with Neurofibromatosis Type 1

• IRAS ID

  123673

• Contact name

  Jonathan Green

• Contact email

  jonathan.green@manchester.ac.uk

• Sponsor organisation

  Central Manchester University Hospital NHS Foundation Trust

• Eudract number

  2012-005742-38

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  13/NW/0111

• Date of REC Opinion

  29 Apr 2013

• REC opinion

  Further Information Favourable Opinion